AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Corsita M 50mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Medley Pharmaceuticals

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Corsita M 50mg/500mg Tablet PR

Diabetica Duo 50mg/500mg tablets manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication helps mitigate serious diabetic complications like vision impairment and kidney disease, potentially lessening heart attack and stroke risk. Diabetica Duo may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and existing medications. Consuming it with meals minimizes stomach upset. Consistent daily intake at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Adherence to your physician's dietary and exercise plan is crucial. Lifestyle significantly influences diabetes management. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and sore throat. Hypoglycemia is possible, especially when combined with insulin or sulfonylureas; learn how to identify and manage this. This medication isn't for everyone. Inform your doctor about pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption. Pregnant or nursing individuals require medical consultation prior to use. Interactions with other medications are possible; disclose all medications to your physician for safety. Alcohol should be limited due to its hypoglycemic effect. Kidney function and blood glucose will be monitored throughout treatment.

Uses of Corsita M 50mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Corsita M 50mg/500mg Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Corsita M 50mg/500mg Tablet PR should be ingested with a meal.

Common Side effects of Corsita M 50mg/500mg Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Corsita M 50mg/500mg Tablet PR:

Follow your physician's instructions or consult the product information leaflet for guidance prior to administration. Corsita M 50mg/500mg Tablet PR should be ingested with a meal.

How Corsita M 50mg/500mg Tablet PR works:

Corsita M 50mg/500mg tablets are a dual-action formulation combining sitagliptin and metformin. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This synergistic effect leads to improved glycemic management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Corsita M 50mg/500mg PR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Corsita M 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Corsita M 50mg/500mg tablets during lactation is likely inadvisable. Available human data indicates potential drug transfer via breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Corsita M 50mg/500mg Tablet PR, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Corsita M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical guidance is recommended.

What if you forget to take Corsita M 50mg/500mg Tablet PR :

Should you forget a Corsita M 50mg/500mg Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Corsita M 50mg/500mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Corsita M 50mg/500mg Tablet PR

Corsita M 50mg/500mg Tablets are a combined Sitagliptin and Metformin treatment for type 2 diabetes in adults. This medication improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while Sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Prolonged use of Corsita M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Corsita M 50mg/500mg Tablet PR may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are possible. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Corsita M 50mg/500mg Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Corsita M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Corsita M 50mg/500mg Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Corsita M 50mg/500mg Tablets are a combination of sitagliptin and metformin, used to treat type 2 diabetes in adults. This medication helps control blood sugar levels when combined with a healthy diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Corsita M 50mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Avoid Corsita M 50mg/500mg Tablet PR if you are allergic to any of its ingredients. It should also be avoided by patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Corsita M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Corsita M 50mg/500mg Tablet PR. This occurs due to elevated blood lactic acid levels. Because it's rare, metformin is avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If these symptoms appear, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Corsita M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Corsita M 50mg/500mg Tablets are a combined Sitagliptin and Metformin treatment for type 2 diabetes in adults. This medication improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while Sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Corsita M 50mg/500mg Tablet PR commonly causes hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rarely, but seriously, it may cause lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Corsita M 50mg/500mg Tablet PR is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Corsita M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Corsita M 50mg/500mg Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume large quantities of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Corsita M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Corsita M 50mg/500mg Tabl...
123